aTyr Pharma's total assets for Q3 2025 were $106.65M, an increase of 5.04% from the previous quarter. ATYR total liabilities were $26.61M for the fiscal quarter, a -1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.